<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04329871</url>
  </required_header>
  <id_info>
    <org_study_id>MetabolicRI</org_study_id>
    <nct_id>NCT04329871</nct_id>
  </id_info>
  <brief_title>Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance</brief_title>
  <official_title>An Analysis of Medtronic 670G Insulin Pump Use in Clinical Practice and the Impact on Glycemic Control, Quality of Life, and Compliance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Metabolic Research Institute, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Metabolic Research Institute, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analyze the Medtronic 670g pump on glycemic control
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An Analysis of the Medtronic 670g Insulin pump use in clinical practice and the impact on
      glycemic control , quality of life, and compliance
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 24, 2020</start_date>
  <completion_date type="Anticipated">March 23, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 23, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic control while using the Medtronic MiniMed 670g system</measure>
    <time_frame>through study completion, an average of 1 year.</time_frame>
    <description>HbA1c, fructosamine, and glycomark will be compared between the participants last visit on previous insulin therapy and the last visit using the pump</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of Quality of Life and satisfaction while using the MiniMed 670g system</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Diabetes Treatment Satisfaction, Diabetes-dependent Quality of Life, and Pump QOL vs Previous Therapy Questionnaires will be completed by each study participant</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who enter the study at Visit 1 and meet all the inclusion criteria and none of the
        exclusion criteria will be eligible to sign informed consent to have their data collected
        and analyzed
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 or older

          -  Documented History of Type 1 Diabetes Mellitus

          -  3 months continuous use of the Medtronic 670g pump system

          -  given written informed consent

        Exclusion Criteria:

          -  Less than 3 months use of the Medtronic 670g pump system

          -  Taking any other medication, other than the insulin used in the Medtronic 670g pump,
             to manage their diabetes

          -  having medical conditions or taking medications that would preclude subject
             involvement or affect the outcomes being measured, in the opinion of the Investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barry S Horowitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Metabolic Research Institute, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paula M Dear</last_name>
    <phone>561-802-3060</phone>
    <phone_ext>8045</phone_ext>
    <email>pdear@metabolic-institute.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adriana Donadio</last_name>
    <phone>561-802-3060</phone>
    <phone_ext>8033</phone_ext>
    <email>adonadio@metabolic-institute.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Metabolic Research Institute</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Dear</last_name>
      <phone>561-802-3060</phone>
      <phone_ext>8045</phone_ext>
      <email>pdear@metabolic-institute.com</email>
    </contact>
    <contact_backup>
      <last_name>Adriana Donadio</last_name>
      <phone>561-802-3060</phone>
      <phone_ext>8033</phone_ext>
      <email>adonadio@metabolic-institute.com</email>
    </contact_backup>
    <investigator>
      <last_name>Barry S Horowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Kaye, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://Metabolic-institute.com</url>
    <description>Company website</description>
  </link>
  <reference>
    <citation>There are no Citations</citation>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>March 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2020</study_first_posted>
  <last_update_submitted>March 31, 2020</last_update_submitted>
  <last_update_submitted_qc>March 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>An article will be written and submitted in a major journal.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>6 months to 1 year</ipd_time_frame>
    <ipd_access_criteria>Company website</ipd_access_criteria>
    <ipd_url>http://metabolic-institute.com</ipd_url>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>http://Metabolic-institute.com</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

